Genocea Biosciences reported $16.04M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US $ 65.49M 4.09M
Baxter International BAX:US $ 3395M 149M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Cytokinetics CYTK:US $ 99.84M 18.14M
Cytori Therapeutics CYTX:US $ 5.12M 1.19M
Genocea Biosciences GNCA:US $ 16.04M 2.63M
Glaxosmithkline GSK:US 5.85B 1.13B
Infinity Pharmaceuticals INFI:US $ 12.7M 355K
Merk MRK:US $ 9666M 666M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Moderna Inc MRNA:US 2.3B 463M
Novavax NVAX:US $ 668.88M 174.21M
Pfizer PFE:US $ 15640M 148M
Prothena PRTA:US 44.52M 5.42M